Bictegravir with emtricitabine and tenofovir alafenamide (Biktarvy®)
Formulary
Darunavir
Formulary
Darunavir with cobicistat (Rezolsta®)
Formulary
Blueteq /prior approval form
Darunavir with cobicistat, emtricitabine and tenofovir alafenamide (Symtuza®)
Formulary
Blueteq /prior approval form
Dolutegravir (Tivicay ®)
Formulary
Dolutegravir with rilpivirine (Juluca®)
Formulary
Fosamprenavir (Telzir®) (tablets)
Formulary
Lopinavir and Ritonavir (Kaletra®) (tablets & solution)
Formulary
Lopinavir with Ritonavir (Oral )
Formulary
Nirmatrelvir With Ritonavir
Formulary
Ritonavir (Oral presentations)
Formulary
05.03.01
Non-nucleoside reverse transcriptase inhibitors
05.03.01
Other antiretrovirals
05.03.01
Pharmacokinetic enhancers of antiretrovirals
05.03.01
Combination Products
....
Non Formulary Items
Darunavir (Prezista®) (tablets)
Non Formulary
Indinavir (Crixivan®)
Non Formulary
Nelfinavir
Non Formulary
Ritonavir (Norvir®) (tablets & SF solution)
Non Formulary
Saquinavir (Invirase®) (tablets)
Non Formulary
Tipranavir (Aptivus®)
Non Formulary
Key
Restricted Drug
Unlicensed
Link to adult BNF
Link to children's BNF
Link to SPCs
Cytotoxic Drug
Controlled Drug
High Cost Medicine
Cancer Drugs Fund
NHS England
Homecare
ICB
Low carbon footprint
Medium carbon footprint
High carbon footprint
Status
Description
Medicines which are suitable for initiation and maintenance prescribing by primary and secondary care clinicians. These medicines should be initiated and prescribed within their licensed indications
Amber Specialist Initiation: Initiation and maintenance of prescribing by Specialists and transfer to Primary Care prescribing when appropriate. This may be supported by a RICaD, annotated within the formulary entry.
Amber Shared Care: Initiation and maintenance of prescribing by Specialists and transfer to Primary Care prescribing, in accordance with an ESCA, annotated within the formulary entry.
Amber Specialist Recommendation: Initiation and maintenance of prescribing in Primary Care following recommendation from a specialist.
Medicines for initiation and maintenance prescribing by Specialists (hospital or GPs with Special Interest) only
Positive NICE TA and /or awaiting local clarification on place in therapy; Please contact your Medicines Optimisation team for more information.
Non-formulary Medicines which APC/Trust DTC has actively reviewed and do not recommend for use.
